Lv2
128 积分 2026-09-09 加入
Association Between Immune Checkpoint Inhibitors Targeting Programmed Cell Death Protein 1 or Programmed Death-Ligand 1 and Type 2 Airway Inflammation in Patients With Lung Cancer: The IMMUNEO Retrospective Case Series
9天前
已关闭
Mulliken and Young's Vascular Anomalies: Hemangiomas and Malformations
14天前
已关闭
A Phase 2 Study of the MEK1/2 Inhibitor Luvometinib in Patients with Extracranial Arteriovenous Malformations
1个月前
已完结
皖公网安备34019202002308
